Next Article in Journal
Superinfection by PHYVV Alters the Recovery Process in PepGMV-Infected Pepper Plants
Next Article in Special Issue
Molecular Basis of the Ternary Interaction between NS1 of the 1918 Influenza A Virus, PI3K, and CRK
Previous Article in Journal
Comment on Liberski, Gajos, Sikorska, and Lindenbaum: “Kuru, the First Human Prion Disease” Viruses 2019, 11, 232
Previous Article in Special Issue
Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques
Review

The Interactions Between HBV and the Innate Immunity of Hepatocytes

1
Stem Cell Research Center, Research Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical College, Shantou 515041, China
2
Department of Nucleic Acid Researches, Genetic Engineering and Biotechnology Research Institute, General Autority-City of Scientific Researches and Technological Applications, Alexandria 21934, Egypt
*
Authors to whom correspondence should be addressed.
Viruses 2020, 12(3), 285; https://doi.org/10.3390/v12030285
Received: 15 February 2020 / Revised: 2 March 2020 / Accepted: 3 March 2020 / Published: 5 March 2020
(This article belongs to the Special Issue Viral Evasion or Suppression of Host Immunity)
Hepatitis B virus (HBV) infection affects ~350 million people and poses a major public health problem worldwide. HBV is a major cause of cirrhosis and hepatocellular carcinoma. Fewer than 5% of HBV-infected adults (but up to 90% of HBV-infected infants and children) develop chronic HBV infection as indicated by continued, detectable expression of hepatitis B surface antigen (HBsAg) for at least 6 months after the initial infection. Increasing evidence indicates that HBV interacts with innate immunity signaling pathways of hepatocytes to suppress innate immunity. However, it is still not clear how HBV avoids monitoring by the innate immunity of hepatocytes and whether the innate immunity of hepatocytes can be effective against HBV if re-triggered. Moreover, a deep understanding of virus–host interactions is important in developing new therapeutic strategies for the treatment of HBV infection. In this review, we summarize the current knowledge regarding how HBV represses innate immune recognition, as well as recent progress with respect to in vitro models for studying HBV infection and innate immunity. View Full-Text
Keywords: HBV; innate immunity; hepatocytes; in-vitro cell models HBV; innate immunity; hepatocytes; in-vitro cell models
Show Figures

Figure 1

MDPI and ACS Style

Megahed, F.A.K.; Zhou, X.; Sun, P. The Interactions Between HBV and the Innate Immunity of Hepatocytes. Viruses 2020, 12, 285. https://doi.org/10.3390/v12030285

AMA Style

Megahed FAK, Zhou X, Sun P. The Interactions Between HBV and the Innate Immunity of Hepatocytes. Viruses. 2020; 12(3):285. https://doi.org/10.3390/v12030285

Chicago/Turabian Style

Megahed, Fayed A.K., Xiaoling Zhou, and Pingnan Sun. 2020. "The Interactions Between HBV and the Innate Immunity of Hepatocytes" Viruses 12, no. 3: 285. https://doi.org/10.3390/v12030285

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop